Globe Life Inc. (NYSE:GL) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Globe Life Inc. (NYSE:GLGet Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $171.3333.

A number of research analysts recently commented on the stock. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Wells Fargo & Company lifted their price objective on Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a report on Wednesday. Truist Financial increased their price target on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Morgan Stanley restated an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. Finally, Evercore set a $157.00 price target on Globe Life in a research report on Wednesday, February 18th.

View Our Latest Research Report on GL

More Globe Life News

Here are the key news stories impacting Globe Life this week:

Globe Life Trading Down 0.5%

NYSE GL opened at $145.32 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life has a 52 week low of $109.38 and a 52 week high of $152.71. The company’s fifty day simple moving average is $141.88 and its 200-day simple moving average is $138.72. The stock has a market cap of $11.43 billion, a P/E ratio of 10.32 and a beta of 0.47.

Globe Life (NYSE:GLGet Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The company’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts predict that Globe Life will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.9%. This is a boost from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date is Thursday, April 2nd. Globe Life’s dividend payout ratio (DPR) is 7.67%.

Insider Buying and Selling at Globe Life

In other news, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $147.91, for a total value of $258,842.50. Following the sale, the director directly owned 3,372 shares in the company, valued at $498,752.52. The trade was a 34.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the transaction, the chief executive officer owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. This represents a 25.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 73,868 shares of company stock worth $10,700,437 in the last quarter. Company insiders own 1.51% of the company’s stock.

Institutional Trading of Globe Life

Several large investors have recently made changes to their positions in the company. Mather Group LLC. bought a new position in Globe Life in the third quarter worth approximately $28,000. Hilton Head Capital Partners LLC bought a new position in Globe Life in the 4th quarter valued at $30,000. CYBER HORNET ETFs LLC purchased a new stake in shares of Globe Life during the 2nd quarter valued at $28,000. Assetmark Inc. raised its stake in shares of Globe Life by 777.8% during the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock worth $29,000 after purchasing an additional 210 shares during the period. Finally, MUFG Securities EMEA plc purchased a new position in shares of Globe Life in the 2nd quarter worth about $31,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

About Globe Life

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Read More

Analyst Recommendations for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.